Cartilage Degeneration Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Type of Treatment (Palliative, Intrinsic Repair Stimulus), By Site of Action (Knee Cartilage Repair), By End User (Hospitals, Diagnostic centres, Orthopaedic Hospitals, Ambulatory surgical centres), and Region Forecast 2020-2031

Cartilage Degeneration Market size was valued at US$ 1.5 billion in 2024 and is expected to reach US$ 4.6 billion by 2031, growing at a significant CAGR of 17.2% from 2025-2031. The global market provides a detailed overview and which can be segmented by treatment modality, application, type of treatment, site of action, end user, and region. By treatment modality, the market has been segmented into cell-based, and non-cell-based. By treatment modality, the cell-based segment held the largest revenue share of the market in past years and is expected to have the fastest growth rate over the forecasted period due rise in cartilage degeneration among various aged people which leads to enhances demand for cell-based cartilage treatment. By application, the market has been segmented into hyaline cartilage and fibrocartilage. By application, the fibrocartilage segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate. By type of treatment, the market has been segmented into palliative and intrinsic repair stimuli. By the site of action, the market has been segmented into knee cartilage repair. The knee segment accounted for the highest share of the market. The growth of this segment is attributed to the increasing prevalence of knee injuries.

For instance, according to a study published in an online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed a massive growth of around 40.0% during the past 4 decades. Furthermore, increasing awareness of the benefits provided by cartilage repair is also anticipated to drive the growth of the knee segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, orthopedic hospitals, and ambulatory surgical centers. The ambulatory surgical clinic segment held the largest share of the market in 2019. Also, the segment is expected to register the highest CAGR in the market during the forecast period.

Key Developments

• In Jan 2021, New Treatment Target was discovered that halts osteoarthritis-like knee cartilage degeneration.